HealthQuill
Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in the US, as demand for the drug increased due to a rise in syphilis infection rates.
Drugs Health Pharma

Pfizer warns of penicillin shortage as syphilis rates rise in United States

HQ Team June 14, 2023: Pfizer Inc. announced a shortage of several doses of penicillin to treat strep throat and other infections in.

Read More
Long-Covid-19 patients have fatigue similar to cancer-related anemia, severe kidney disease, and Parkinson’s disease, a study by the  University College of London found.
Drugs Health Pharma

Fatigue in long Covid patients same as in stage IV lung cancer

HQ Team June 14, 2023: Long-Covid-19 patients have fatigue similar to cancer-related anemia, severe kidney disease, and Parkinson’s disease, a study by the .

Read More
Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9% vaccination success rate.
Drugs Medical Pharma

France’s Valneva says trial vaccine for chikungunya post 98.9% rate

HQ Team June 13, 2023: Valneva SE, a French vaccine maker, announced that its last-stage trials for its single-shot chikungunya registered a 98.9%.

Read More
Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the country to make new active pharmaceutical ingredients.
Drugs Health Pharma

Novo Nordisk to invest $2.3 billion to expand Danish facility 

HQ Team June 13, 2023: Denmark’s Novo Nordisk will invest 15.9 billion kroner ($2.30 billion) to expand its Hillerød production facility in the.

Read More
Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental trials of two drugs to treat chronic kidney diseases.
Drugs Health Pharma

Novartis to acquire Chinook Therapeutics in a $3.5 billion deal

HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.

Read More
A public inquiry starts today in Britain, into the nation’s handling of the Covid-19 pandemic, which killed 224,546 people in the country.
Drugs Health Pharma

Britain’s public inquiry into Covid-19 pandemic to start today

HQ Team June 13, 2023: A public inquiry starts today in Britain, into the nation’s handling of the Covid-19 pandemic, which killed 224,546.

Read More
A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease and multiple sclerosis, researchers say.
Drugs Health Pharma

Alzheimer’s develops when hero microglia turns into a villain in brain

HQ Team June 11, 2023: A blood protein, called fibrin, which supports clotting, is responsible for switching on detrimental genes in Alzheimer’s disease.

Read More
STIs
Drugs Health Medical

Doxycycline demonstrates potential in preventing STIs among high-risk individuals

HQ Team June 10, 2023: A study, funded by the National Institute of Allergy and Infectious Diseases (NIAID), found that using the oral.

Read More
gene editing
Drugs Health Medical Pharma

FDA considering approval for first ever CRISPR gene editing technology drug

HQ Team June 10, 2023:The Food and Drug Administration (FDA) has accepted an application for what could become the first-ever marketed medicine based.

Read More
An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug nirsevimab, meant to treat lower respiratory tract disease in newborns, according to a statement from the Paris-based firm.
Drugs Health Pharma

FDA’s advisory panel backs Sanofi, AstraZeneca’s investigational drug for newborns

HQ Team June 9, 2023: An advisory committee of the USFDA has given a “favourable benefit-risk profile” for Sanofi and AstraZeneca’s experimental drug.

Read More